Wild 20

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581387

CAS#: 152784-11-7

Description: Wild 20 is a breakdown product of G(M1) ganglioside; has antiplatelet effect & prolonged bleeding time without interfering with the coagulative or fibrinolytic processes.


Chemical Structure

img
Wild 20
CAS# 152784-11-7

Theoretical Analysis

MedKoo Cat#: 581387
Name: Wild 20
CAS#: 152784-11-7
Chemical Formula: C53H97N3O28
Exact Mass: 1,223.63
Molecular Weight: 1,224.350
Elemental Analysis: C, 51.99; H, 7.99; N, 3.43; O, 36.59

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Wild 20; Wild-20; Wild20; De-N-acetyllysoGM1;

IUPAC/Chemical Name: (2S,4S,5R,6S)-5-amino-2-(((2S,3R,4R,5S,6S)-2-(((2S,3S,4R,5R,6R)-6-(((2R,3S,Z)-2-amino-3-hydroxyicos-4-en-1-yl)oxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-5-(((2S,3R,4R,5R,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)-4-(((2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-4-hydroxy-6-((1S,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid

InChi Key: RINPOXNCRXGFAV-LPKLQDSVSA-N

InChi Code: InChI=1S/C53H97N3O28/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(62)25(54)24-75-49-41(71)39(69)43(31(22-60)78-49)80-51-42(72)47(84-53(52(73)74)18-27(63)33(55)46(83-53)35(65)28(64)19-57)44(32(23-61)79-51)81-48-34(56)45(37(67)30(21-59)76-48)82-50-40(70)38(68)36(66)29(20-58)77-50/h16-17,25-51,57-72H,2-15,18-24,54-56H2,1H3,(H,73,74)/b17-16-/t25-,26+,27+,28-,29-,30-,31+,32+,33-,34-,35+,36+,37+,38-,39-,40-,41-,42-,43-,44+,45-,46+,47-,48+,49-,50+,51+,53+/m1/s1

SMILES Code: C(\CCCCCCCCCCCCCCC)=C\[C@@H]([C@@H](CO[C@H]1[C@@H]([C@@H](O)[C@@H]([C@H](CO)O1)O[C@H]1[C@@H]([C@@H](O[C@@]2(C[C@H](O)[C@@H](N)[C@@H]([C@H]([C@@H](CO)O)O)O2)C(O)=O)[C@H]([C@H](CO)O1)O[C@H]1[C@H](N)[C@@H](O[C@@H]2O[C@@H]([C@H](O)[C@@H](O)[C@H]2O)CO)[C@H]([C@H](O1)CO)O)O)O)N)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 1,224.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pérez JA, Sánchez-García C, Díez C, Bartolomé DJ, Alonso ME, Gaudioso VR. Are
parent-reared red-legged partridges (Alectoris rufa) better candidates for
re-establishment purposes? Poult Sci. 2015 Oct;94(10):2330-8. doi:
10.3382/ps/pev210. Epub 2015 Sep 10. PubMed PMID: 26362976.


2: Di Minin E, Laitila J, Montesino-Pouzols F, Leader-Williams N, Slotow R,
Goodman PS, Conway AJ, Moilanen A. Identification of policies for a sustainable
legal trade in rhinoceros horn based on population projection and socioeconomic
models. Conserv Biol. 2015 Apr;29(2):545-55. doi: 10.1111/cobi.12412. Epub 2014
Oct 20. PubMed PMID: 25331485; PubMed Central PMCID: PMC4405060.


3: Ogunkunle AT, Oyelakin TM, Enitan AO, Oyewole FE. A quantitative documentation
of the composition of two powdered herbal formulations (antimalarial and
haematinic) using ethnomedicinal information from ogbomoso, Nigeria. Evid Based
Complement Alternat Med. 2014;2014:751291. doi: 10.1155/2014/751291. Epub 2014
Feb 20. PubMed PMID: 24701246; PubMed Central PMCID: PMC3950644.


4: Asami DK, McDonald RB, Hagopian K, Horwitz BA, Warman D, Hsiao A, Warden C,
Ramsey JJ. Effect of aging, caloric restriction, and uncoupling protein 3 (UCP3)
on mitochondrial proton leak in mice. Exp Gerontol. 2008 Dec;43(12):1069-76. doi:
10.1016/j.exger.2008.09.010. Epub 2008 Sep 30. PubMed PMID: 18852040; PubMed
Central PMCID: PMC2614627.


5: Tubaro E, Borelli GP, Belogi L, Cavallo G, Santoni A, Mainiero F. Effect of a
new de-N-acetyl-lysoglycosphingolipid on some tumour models. Eur J Pharmacol.
1995 Dec 29;294(2-3):555-63. PubMed PMID: 8750718.


6: Tubaro E, Croce C, Cavallo G, Belogi L, Guida G, Santiangeli C, Cifone MG,
Santoni A, Mainiero F. In vitro and in vivo impact of a new glycosphingolipid on
neutrophils. Agents Actions. 1994 Oct;42(3-4):107-13. PubMed PMID: 7879694.


7: Tubaro E, Santiangeli C, Cavallo G, Belogi L, Guida G, Croce C, Modesti A.
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced
inflammatory bowel disease: possible mechanism of action. Naunyn Schmiedebergs
Arch Pharmacol. 1993 Dec;348(6):670-8. PubMed PMID: 8133910.


8: Tubaro E, Belogi L, Croce C, Cavallo G, Guida G, Borelli GP. Antiplatelet
effects of a new de-N-acetyl-lyso-glycosphingolipid. Eur J Pharmacol. 1993 Aug
2;248(2):175-83. PubMed PMID: 8223963.